TGTX
TG Therapeutics Inc
54.30$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.5% | -30.0% | -12.9% | 7.5% | -14.6% | -23.7% | -23.8% | 5.3% | -14.3% | 10.2% | -8.7% | 8.9% | 0.0% | |
| 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 3.9% | 0.0% | 0.0% | 1.0% | |
| 5.5% | 21.3% | 14.7% | 12.9% | 14.0% | 11.0% | 12.4% | 11.6% | 10.9% | 8.1% | 9.7% | 19.9% | 12.6% | |
| -24.2% | -18.3% | -9.6% | -14.5% | -37.9% | -56.1% | -40.2% | -26.0% | -40.0% | -23.1% | -34.0% | -27.7% | -30.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | |
| -18.2% | -101.8% | -14.6% | 2.4% | -11.1% | 14.6% | -10.7% | -2.8% | 28.7% | -8.1% | -4.8% | -3.7% | 1.5% | |
| 0.0% | – | – | – | – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | |
| – | 0.0% | 0.0% | 0.0% | -2.6% | -6.1% | -5.1% | -4.9% | -48.4% | -9.9% | -48.8% | -41.6% | -37.2% | |
| – | – | – | – | 163.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 240.4% | 0.0% | 61.6% | |
| 0.3% | 0.0% | 0.0% | 0.2% | 160.3% | -5.6% | -5.0% | -4.6% | -48.4% | 0.5% | 190.7% | 162.7% | 88.1% | |
| 32.5% | -131.8% | -27.5% | 10.1% | 134.6% | -14.7% | -39.5% | -2.1% | -34.0% | 2.6% | 177.2% | 167.9% | 89.6% | |
| 50.5% | -30.0% | -12.9% | 7.5% | -14.6% | -23.7% | -23.8% | 5.2% | -14.4% | 10.2% | -8.8% | 8.7% | -0.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.